These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4623214)

  • 61. Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.
    Elsässer-Beile U; Leiber C; Wetterauer U; Bühler P; Wolf P; Lucht M; Mengs U
    Anticancer Res; 2005; 25(6C):4733-6. PubMed ID: 16334168
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.
    Wescott JW
    J Urol; 1966 Dec; 96(6):913-8. PubMed ID: 4959545
    [No Abstract]   [Full Text] [Related]  

  • 63. Bladder hyperthermia in the treatment of vesical papillomatosis.
    Lunglmayr G; Czech K; Zekert F; Kellner G
    Int Urol Nephrol; 1973 Jan; 5(1):75-84. PubMed ID: 4203803
    [No Abstract]   [Full Text] [Related]  

  • 64. [Serious complications following topical administration of thio-tepa in a patient with bladder carcinoma].
    Kaczmarek A
    Wiad Lek; 1978 Apr; 31(8):547-50. PubMed ID: 96607
    [No Abstract]   [Full Text] [Related]  

  • 65. [Local chemotherapy of bladder epitheliomas].
    Martinez-Piñeiro JA
    Acta Oncol (Madr); 1970; 9(1):1-27. PubMed ID: 4990619
    [No Abstract]   [Full Text] [Related]  

  • 66. Intracavitary chemotherapy for multiple non-invasive bladder tumours.
    Riddle PR; Wallace DM
    Br J Urol; 1971 Apr; 43(2):181-4. PubMed ID: 4996213
    [No Abstract]   [Full Text] [Related]  

  • 67. [Combination chemotherapy of mitomycin C and cytosine arabinoside in the intravesical treatment for superficial bladder tumors: report 2. Evaluation of prophylactic intravesical infusion therapy].
    Ikeuchi T; Onodera Y; Kai Y
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):858-63. PubMed ID: 6426397
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intravesical chemotherapy in the management of superficial bladder tumors.
    Schulman CC
    Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356
    [No Abstract]   [Full Text] [Related]  

  • 69. [Photodynamic therapy of superficial cancer of the urinary bladder to prevent relapse].
    Rusakov IG; Sokolov VV; Bystrov AA
    Vopr Onkol; 2006; 52(6):675-9. PubMed ID: 17338248
    [No Abstract]   [Full Text] [Related]  

  • 70. Intravesical thiotepa in the treatment of transitional cell bladder carcinoma.
    Mitchell RJ
    Br J Urol; 1971 Apr; 43(2):185-8. PubMed ID: 4996214
    [No Abstract]   [Full Text] [Related]  

  • 71. Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer.
    Jauhiainen K; Alfthan O
    Ann Chir Gynaecol; 1984; 73(4):206-10. PubMed ID: 6508201
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Personal experience with thio-tepa in the treatment of papillomas and superficial carcinomas of the bladder].
    Pellet A; Djulepa J
    Ther Umsch; 1970 May; 27(5):310-3. PubMed ID: 4994886
    [No Abstract]   [Full Text] [Related]  

  • 73. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin].
    Nogueira March JL; Ojea A; Jamardo D; Figueiredo L
    Actas Urol Esp; 1984; 8(4):325-8. PubMed ID: 6435407
    [No Abstract]   [Full Text] [Related]  

  • 74. Absorption studies on intraluminal thio-tepa for topical cytostatic treatment of low-stage bladder tumors.
    Lunglmayr G; Czech K
    J Urol; 1971 Jul; 106(1):72-4. PubMed ID: 4998357
    [No Abstract]   [Full Text] [Related]  

  • 75. [Tumors of the superior urinary tract and associated bladder tumors: clinical and etiological aspects].
    Bretheau D; Lechevallier E; Jean F; Rampal M; Coulange C
    Prog Urol; 1993 Dec; 3(6):979-87. PubMed ID: 8305941
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30mg/40ml, 40mg/40ml.
    Kuroda M; Niijima T; Kotake T; Akaza H; Hinotsu S;
    Eur Urol; 2004 May; 45(5):600-5. PubMed ID: 15082202
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.
    Dobrzecki W; Kaczmarek A
    Int Urol Nephrol; 1977; 9(2):145-9. PubMed ID: 412808
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patient instructions for bladder installation of Thiotepa.
    Howe SM
    AUAA J; 1986; 6(3):6. PubMed ID: 2938564
    [No Abstract]   [Full Text] [Related]  

  • 79. Chemotherapy of bladder tumours.
    Pavone-Macaluso M
    Urol Res; 1978; 6(4):259-62. PubMed ID: 105444
    [No Abstract]   [Full Text] [Related]  

  • 80. Treatment of superficial bladder cancer.
    Morales A
    Can Med Assoc J; 1980 May; 122(10):1133-8. PubMed ID: 6770987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.